AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Flexjak 5mg Tablet

Prescription Icon
Prescription Required

Marketer

Abbott Healthcare Private Limited

Salt Composition

Tofacitinib (5mg)

Overview Flexjak 5mg Tablet

ArthriCare 5mg tablets effectively manage moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation and hindering further bone and joint deterioration. ArthriCare 5mg may be administered alone or alongside other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is tailored to individual needs and other concurrent medications, always as directed by your physician. Discontinue use only under your doctor's guidance, as abrupt cessation could exacerbate your condition. Common side effects include upper respiratory infections, headache, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects such as blood clots and gastrointestinal perforations require immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood tests may be necessary, and treatment should not commence if you have an active infection. Consult your doctor before starting treatment if you have a history of tuberculosis, shingles, hepatic or renal disease, hepatitis B or C, or pulmonary or leg blood clots. ArthriCare 5mg can increase infection susceptibility; avoid contact with contagious individuals (e.g., those with chickenpox, measles, influenza). This medication is unsuitable for individuals under 18 years and should be avoided during pregnancy or breastfeeding unless the potential benefits outweigh the risks as determined by your physician. Regular check-ups with your doctor may be necessary.

Uses of Flexjak 5mg Tablet

Management strategies for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Flexjak 5mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consumption of the Flexjak 5mg Tablet may coincide with or precede meals; however, consistent daily timing is recommended.

Common Side effects of Flexjak 5mg Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Flexjak 5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Flexjak 5mg Tablets can be consumed with or without food, although consistent timing is recommended.

How Flexjak 5mg Tablet works:

Janus kinase inhibitor Flexjak 5mg tablets suppress the activity of the Janus kinase enzyme. This mechanism reduces immune system activity and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingestion of alcohol alongside Flexjak 5mg Tablet presents no adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Flexjak 5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Flexjak 5mg tablets while breastfeeding is likely inadvisable. Preliminary data in humans indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Flexjak 5mg Tablets.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the use of 5mg Flexjak tablets requires careful consideration. A modified dosage of Flexjak 5mg tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Flexjak 5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Flexjak 5mg Tablet :

Should you forget to take a Flexjak 5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Flexjak 5mg Tablet

LabelValue
Type of Compound Pyrrolopyrimidine compound
Addictive None.
Medication Classification Pain relievers
Mechanism of Action JAK inhibitors

FAQs on Flexjak 5mg Tablet

Patients with liver conditions should consult their physician prior to commencing treatment with Flexjak 5mg Tablet. This precaution is necessary as Flexjak 5mg Tablet may elevate liver enzyme levels in some individuals, necessitating a liver function assessment before initiating therapy. While Flexjak 5mg Tablet may be administered to those with mild to moderate hepatic impairment, its use is contraindicated in patients exhibiting severe liver dysfunction.
Taking Flexjak 5mg tablets might raise the likelihood of specific cancers, such as lymphoma and various skin cancers, due to its impact on the immune system. Therefore, disclose any history of cancer to your physician.
Rheuma-5, a 5mg tablet, treats moderate to severe rheumatoid arthritis, a joint inflammatory condition. This medication is indicated when prior treatments proved ineffective or unsuitable. Alternatively, it may be initiated early if initial drug regimens fail to provide adequate relief. Rheuma-5 can be administered independently or concurrently with other medications, including methotrexate.
The noticeable benefits of Flexjak 5mg Tablet typically emerge within two to eight weeks, with the full therapeutic effect often achieved within three to six months.
Prior to commencing or during treatment with Flexjak 5mg Tablet, blood work may be required. These tests assess for anemia (low red blood cell count), neutropenia or lymphopenia (low white blood cell count), elevated cholesterol (high blood fat), and high liver enzyme levels. This monitoring helps determine if Flexjak 5mg Tablet is causing adverse effects. Furthermore, your physician might recommend a tuberculosis test before initiating Flexjak 5mg Tablet therapy, as the medication could exacerbate a pre-existing infection.
Flexjak 5mg tablets modulate the immune system, potentially lowering resistance to infection and raising the risk of severe infections, such as tuberculosis. This increased susceptibility encompasses serious fungal, bacterial, or viral infections with systemic spread. Such infections may be life-threatening and fatal, necessitating in-hospital management.
Concurrent use of tocilizumab and Flexjak 5mg Tablet is contraindicated. Flexjak 5mg Tablet's immunosuppressive properties necessitate avoidance of concomitant administration with other immunomodulatory drugs. Combining these medications elevates the infection risk and potentially exacerbates adverse effects.
Flexjak 5mg Tablet
205
MRP 250
18% off